Adams Street and Latterell lead Naurex’s $18mm Series A financing
Adams Street Partners and Latterell Venture Partners co-led neurology therapeutics developer Naurex Inc.’s $18mm Series A financing, which also included investments by Druid BioVentures, Genesys Capital, PathoCapital, H. Lundbeck AS, Takeda Ventures, and Shire PLC. A member of PathoCapital has become the company’s chairman, and executives from Adams and Latterell joined the board.
- Drug Discovery Tools
- Large Molecule
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com